Treatment of multiple sclerosis with laquinimod

• 收藏
• 分享

专利权人:

Ltd.;Teva Pharmaceutical Industries

发明人:

Tarcic, Nora,Bar-Zohar, Dan,Kofler, Dina

申请号：

AU2016216586

公开号：

AU2016216586A1

申请日:

2016.08.16

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016216586A120160901.pdf#####Abstract of the Disclosure The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsingremitting multiple sclerosis human patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/